The cost of developing and taking a new drug to market can range from a hair under a billion to almost $3bn, with a study from the London School of Economics giving an average of $1.3bn.
It also takes typically between 10 and 15 years. Imjudo (tremelimumab-actl) for example, was approved in October 2022 after nearly...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?